CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 48 enrolled
Drug / intervention
Ondansetron (ODFS) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01217801
NCT01217801Phase 1Completed

Open-label Randomized, Two Way Crossover Bioequivalence Study to Compare Ondansetron Orally Dissolving FilmStrip 8mg With Zofran Orally Disintegrating Tablets 8 mg in 48 Healthy, Adult, Participants Under Fed Conditions.

MonoSol Rx·interventional·Posted Oct 8, 2010·Updated May 2, 2017

In Brief

A Phase 1 clinical trial evaluating Ondansetron (ODFS) and Ondansetron (ODT) for Healthy. Completed, enrolled 48 participants across 1 site.

Detailed Summary

The purpose of this study is to assess the single dose bioequivalence of Ondansetron ODFS 8mg with Zofran ODT® (Containing Ondansetron 8 mg) in healthy, male and female adult, human study participants under fed conditions. The purpose is to monitor clinical status, adverse events, laboratory investigations and to assess relative safety and tolerance of ondansetron formulations under fed conditions.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesIndia
Collaborators--

Timeline

Phase 1CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 8, 2010
Enrollment StartOct 1, 2008
Primary CompletionOct 1, 2008
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 15.7 years ago

Interventions

Ondansetron (ODFS)drug

Ondansetron Orally Dissolving Filmstrip Ondansetron (ODFS)

Ondansetron (ODT)drug

Ondansetron Orally Disintegrating Tablet Ondanestron (ODT)